Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: A Brugada syndrome variant?

Journal of Cardiovascular Electrophysiology

Volumn 11, Issue 1, 2000, Pages 95-98

  Kalla, Hari ^a   Yan, Gan Xin ^a,b   Marinchak, Roger ^a  

^a LANKENAU HOSPITAL   (United States)

^b Cardiology Foundation of Lankenau   (United States)

Author keywords

Amiodarone; J (Osborn) wave; Sudden unexplained nocturnal death syndrome; Ventricular fibrillation

Indexed keywords

AMIODARONE; DIGOXIN; LIDOCAINE; PROCAINAMIDE; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; DEFIBRILLATOR; ELECTROCARDIOGRAM; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

EID: 0033967941     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2000.tb00743.x     Document Type: Article

References (26)

1. 1. Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report. J Am Coll Cardiol 1992;20:1391-1396.
2. 2. Antzelevitch C: The Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:513-516.
3. 3. Gussak I, Antzelevitch C, Bjerregaard P, et al: The Brugada syndrome: Clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999;33:5-15.
4. 4. Otto CM, Tauxe RV, Cobb LA, et al: Ventricular fibrillation causes sudden death in Southeast Asian immigrants. Ann Intern Med 1984;100:45-47.
5. 5. Nademanee K, Veerakul G, Nimmannit S, et al: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-2600.
6. 6. Nademanee K: Sudden unexplained death syndrome in Southeast Asia. Am J Cardiol 1997;79(6A):10-11.
7. 7. Scheinman MM: Is the Brugada syndrome a distinct clinical entity? J Cardiovasc Electrophysiol 1997;8:332-336.
8. 8. Park HY, Weinstein SR: Sudden unexpected nocturnal death syndrome in the Mariana Islands. Am J Forensic Med Pathol 1990; 11:205-207.
9. 9. Gussak I, Bjerregaard P, Egan TM, et al: ECG phenomenon called the J wave. History, pathophysiology, and clinical significance. J Electrocardiol 1995;28:49-58.
10. 10. Yan GX, Antzelevitch C: Cellular basis for the electrocardiographic J wave. Circulation 1996;93:372-379.
11. 11. Aizawa Y, Tamura M, Chinushi M, et al: An attempt at electrical catheter ablation of the arrhythmogenic area in idiopathic ventricular fibrillation. Am Heart J 1992;123:257-260.
12. 12. Aizawa Y, Tamura M, Chinushi M, et al: Idiopathic ventricular fibrillation and bradycardia-dependent intraventricular block. Am Heart J 1993;126:1473-1474.
13. 13. Yan GX, Antzelevitch C: Cellular basis for idiopathic VT/VF syndrome. (Abstract) Circulation 1996;94:1-625.
14. 14. Yan GX, Antzelevitch C: Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 1999;100:1660-1666.
15. 15. Antzelevitch C, Yan GX, Shimizu W, et al: Electrical hetereogeneity, the ECG, and cardiac arrhythmias. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders, Philadelphia, 1999; 222-238.
16. 16. Krishnan SC, Antzelevitch C: Flecainide-induced arrhythmia in canine ventricular epicardium: Phase 2 reentry? Circulation 1993; 87:562-572.
17. 17. Lukas A, Antzelevitch C: Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4-aminopyridine. Cardiovasc Res 1996;32:593-603.
18. 18. Miyazaki T, Mitamura H, Miyoshi S, et al: Autonomic and anti-arrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061-1070.
19. 19. Kasanuki H, Ohnishi S, Ohtuka M, et al: Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997;95:2277-2285.
20. 20. Matsuo K, Shimizu W, Kurita T, et al: Dynamic changes of 12-lead electrograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:508-512.
21. 21. Lukas A: Electrophysiology of myocardial cells in the epicardial, midmyocardial and endocardial layers of the ventricle. J Cardiovasc Pharmacol Ther 1997;2:61-72.
22. 10 and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol 1996;271:H548-H561.
23. 23. Kocic I, Korolkiewicz KZ: Digoxin effects in the guinea pig heart: Interaction with rimalkalim. Pharmacol Res 1998;37:67-73.
24. 24. Imaizumi Y, Giles WR: Quinidine-induced inhibition of transient outward current in cardiac muscle. Am J Physiol 1987;253:H704-H708.
25. 25. Guo W, Kamiya K, Toyama J: Evidence of antagonism between amiodarone and triiodothyronine on the K+ channel activities of cultured rat cardiomyocytes. J Mol Cell Cardiol 1997;29:617-627.
26. 26. Nakamura W, Segawa K, Ito H, et al: Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia. J Cardiovasc Electrophysiol 1998;9:855-858.